Therapix Biosciences

YTD

ALL

Why Robinhood?

You can watch TRPXY and buy or sell other stocks, ETFs, and their options commission-free!

About TRPXY

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs.

CEO

Oz Adler, CPA

CEOOz Adler, CPA

Employees

—

Employees—

Headquarters

Tel Aviv, Tel Aviv

HeadquartersTel Aviv, Tel Aviv

Founded

2004

Founded2004

Employees

—

Employees—

TRPXY Key Statistics

Market cap

9.08M

Market cap9.08M

Price-Earnings ratio

-0.31

Price-Earnings ratio-0.31

Dividend yield

—

Dividend yield—

Average volume

6.01K

Average volume6.01K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$12.25

52 Week high$12.25

52 Week low

$2.75

52 Week low$2.75